Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16612487 | 1.00 | GSK3B (0.32) | GSK3B | |
| SCHEMBL31557550 | 0.78 | NSD2 (0.34) | GSK3B | |
| SCHEMBL21233470 | 0.71 | — | — | |
| SCHEMBL2035037 | 0.67 | GSK3A (0.52) | GSK3B | |
| SCHEMBL8733759 | 0.61 | — | — | |
| SCHEMBL6851025 | 0.58 | GSK3B (0.44) | GSK3B | |
| SCHEMBL7429649 | 0.57 | THRB (0.55) | GSK3B | |
| SCHEMBL441276 | 0.57 | PPOX (0.46) | GSK3B | |
| SCHEMBL9061974 | 0.57 | — | — | |
| SCHEMBL29104193 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160238611-A1 | NON-RIBOSOMAL PROTEIN SYNTHESIS PIGMENT FUSION PEPTIDES | DEUTSCHES KREBSFORSCH (DE) | 2016-08-18 | — | — | US | disclosed |
| WO-2015049335-A1 | NON-RIBOSOMAL PROTEIN SYNTHESIS PIGMENT FUSION PEPTIDES | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2015-04-09 | — | — | WO | disclosed |
| EP-2857416-A1 | Non-ribosomal protein synthesis pigment fusion peptides | Deutsches Krebsforschungszentrum (DE) | 2015-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160238611-A1 | NON-RIBOSOMAL PROTEIN SYNTHESIS PIGMENT FUSION PEPTIDES | NPEPPS, INCENP, RRP15 | GSK3B 4446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.